BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29556691)

  • 41. Whole-lesion histogram and texture analyses of breast lesions on inline quantitative DCE mapping with CAIPIRINHA-Dixon-TWIST-VIBE.
    Sun K; Zhu H; Chai W; Zhan Y; Nickel D; Grimm R; Fu C; Yan F
    Eur Radiol; 2020 Jan; 30(1):57-65. PubMed ID: 31372782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Texture Analysis of Three-Dimensional MRI Images May Differentiate Borderline and Malignant Epithelial Ovarian Tumors.
    Ye R; Weng S; Li Y; Yan C; Chen J; Zhu Y; Wen L
    Korean J Radiol; 2021 Jan; 22(1):106-117. PubMed ID: 32932563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Value of conventional magnetic resonance imaging texture analysis in the differential diagnosis of benign and borderline/malignant phyllodes tumors of the breast.
    Li X; Jiang N; Zhang C; Luo X; Zhong P; Fang J
    Cancer Imaging; 2021 Mar; 21(1):29. PubMed ID: 33712070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of Diffusion Kurtosis Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Differentiating Benign and Malignant Head and Neck Lesions.
    Cheng J; Shao S; Chen W; Zheng N
    J Magn Reson Imaging; 2022 Feb; 55(2):414-423. PubMed ID: 34378259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic value of dynamic contrast enhancement combined with conventional MRI in differentiating benign and malignant lacrimal gland epithelial tumours.
    Jian T; Yang M; Wu T; Ji X; Xia S; Sun F
    Clin Radiol; 2024 Mar; 79(3):e345-e352. PubMed ID: 37953093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DCE-MR imaging of orbital lesions: diagnostic performance of the tumor flow residence time τ calculated by a multi-compartmental pharmacokinetic tumor model based on individual factors.
    Erb-Eigner K; Asbach P; Ro SR; Haas M; Bertelmann E; Pietsch H; Schwenke C; Taupitz M; Denecke T; Hamm B; Lawaczeck R
    Acta Radiol; 2019 May; 60(5):643-652. PubMed ID: 30114927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of proton MR spectroscopy in the differentiation of borderline from malignant epithelial ovarian tumors: A preliminary study.
    Ma FH; Li YA; Liu J; Li HM; Zhang GF; Qiang JW
    J Magn Reson Imaging; 2019 Jun; 49(6):1684-1693. PubMed ID: 30353967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
    Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
    Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of Volumetric Perfusion Quantitative Parameters Using CS-VIBE Breast Dynamic Contrast Enhanced MR Imaging.
    Chang YW; Lee EJ; Hwang J; Nickel D; Sung JK
    Curr Med Imaging; 2023; 19(11):1286-1294. PubMed ID: 36165524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The enhanced T
    Han X; Sun M; Wang M; Fan R; Chen D; Xie L; Liu A
    Eur J Radiol; 2019 Sep; 118():187-193. PubMed ID: 31439240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of quantitative dynamic contrast-enhanced MRI in distinguishing different histologic grades of breast phyllode tumor.
    Yi Z; Xie M; Shi G; Cheng Z; Zeng H; Jiang N; Wu Z
    Eur Radiol; 2022 Mar; 32(3):1601-1610. PubMed ID: 34491383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki-67 expression.
    Li HM; Zhao SH; Qiang JW; Zhang GF; Feng F; Ma FH; Li YA; Gu WY
    J Magn Reson Imaging; 2017 Nov; 46(5):1499-1506. PubMed ID: 28295854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MRI-Based Machine Learning for Differentiating Borderline From Malignant Epithelial Ovarian Tumors: A Multicenter Study.
    Li Y; Jian J; Pickhardt PJ; Ma F; Xia W; Li H; Zhang R; Zhao S; Cai S; Zhao X; Zhang J; Zhang G; Jiang J; Zhang Y; Wang K; Lin G; Feng F; Lu J; Deng L; Wu X; Qiang J; Gao X
    J Magn Reson Imaging; 2020 Sep; 52(3):897-904. PubMed ID: 32045064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential diagnosis of thyroid nodules by DCE-MRI based on compressed sensing volumetric interpolated breath-hold examination: A feasibility study.
    Huang J; Liu D; Chen J; Wang X; Tang L; Zhang J; Tan Y; Lan X; Yin T; Nickel D; Wu J; Zhang J
    Magn Reson Imaging; 2024 Sep; 111():138-147. PubMed ID: 38729225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of orbital masses by multiparametric MRI.
    Ro SR; Asbach P; Siebert E; Bertelmann E; Hamm B; Erb-Eigner K
    Eur J Radiol; 2016 Feb; 85(2):324-36. PubMed ID: 26781137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differentiation of benign from malignant adnexal masses by functional 3 tesla MRI techniques: diffusion-weighted imaging and time-intensity curves of dynamic contrast-enhanced MRI.
    Malek M; Pourashraf M; Mousavi AS; Rahmani M; Ahmadinejad N; Alipour A; Hashemi FS; Shakiba M
    Asian Pac J Cancer Prev; 2015; 16(8):3407-12. PubMed ID: 25921153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diffusion weighted imaging and perfusion weighted imaging in the differential diagnosis of benign and malignant renal masses on 3.0 T MRI].
    Xu X; Wang P; Ma L; Shao Z; Zhang M
    Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(3):200-4. PubMed ID: 25877031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differentiation of bone metastases from prostate cancer and benign red marrow depositions of the pelvic bone with multiparametric MRI.
    Park S; Park JG; Jun S; Kim H; Kim TS; Kang H
    Magn Reson Imaging; 2020 Nov; 73():118-124. PubMed ID: 32860869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative transport mapping (QTM) for differentiating benign and malignant breast lesion: Comparison with traditional kinetics modeling and semi-quantitative enhancement curve characteristics.
    Zhang Q; Spincemaille P; Drotman M; Chen C; Eskreis-Winkler S; Huang W; Zhou L; Morgan J; Nguyen TD; Prince MR; Wang Y
    Magn Reson Imaging; 2022 Feb; 86():86-93. PubMed ID: 34748928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
    Lu S; Gao Q; Yu J; Li Y; Cao P; Shi H; Hong X
    Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.